The present invention relates to novel alkyl amino substituted naphtho [1, 2-d] oxazoles. More particularly the present invention is relates to the novel naphtha [1, 2-d] oxazole phenoxy-subsitutied alkyl amino derivaties, their preparation and use as anti-hyperglycemic agents (Anti-diabetic) and for the treatment and prevention of cardiovascular disorders (CVS) The main objective of the present invention is to provide agents to act in non insulin dependent diabetes mellitus (NIDDM) with the added advantage of their effect in the treatment and prevention of CVS disorders.
